Thomas A. Hurwich Net Worth

The estimated Net Worth of Thomas A. Hurwich is at least $5.9 Million dollars as of 28 February 2017. Thomas Hurwich owns over 2,311 units of AbbVie stock worth over $5,505,868 and over the last 7 years Thomas sold ABBV stock worth over $396,299.

Thomas Hurwich ABBV stock SEC Form 4 insider trading

Thomas has made over 12 trades of the AbbVie stock since 2013, according to the Form 4 filled with the SEC. Most recently Thomas sold 2,311 units of ABBV stock worth $143,028 on 28 February 2017.

The largest trade Thomas’s ever made was exercising 11,503 units of AbbVie stock on 14 August 2013 worth over $316,678. On average, Thomas trades about 2,745 units every 62 days since 2013. As of 28 February 2017 Thomas still owns at least 67,276 units of AbbVie stock.

You can see the complete history of Thomas Hurwich stock trades at the bottom of the page.

What’s Thomas Hurwich’s mailing address?

Thomas’s mailing address filed with the SEC is 1 N. WAUKEGAN ROAD, , NORTH CHICAGO, IL, 60064.

Insider trading at AbbVie

Over the last 7 years, insiders at AbbVie have traded over $114,130,047 worth of AbbVie stock and bought 207,390 units worth $13,938,118 . The most active insider traders include Richard A Gonzalez, Frederick H Waddell, and Glenn F Tilton. On average, AbbVie executives and independent directors trade stock every 21 days with the average trade being worth of $2,604,067. The most recent stock trade was executed by Timothy J. Richmond on 27 September 2019, trading 15,515 units of ABBV stock currently worth $1,163,935.

What does AbbVie do?

AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology and dermatology; oncology, including blood cancers; virology, including hepatitis C virus (HCV) and human immunodeficiency virus (HIV); neurological disorders, such as as well as Parkinson’s disease; metabolic diseases, comprising thyroid disease and complications associated with cystic fibrosis; pain associated with endometriosis; and other serious health conditions. The company was founded on October 19, 2011 and is headquartered in North Chicago, IL.

What does AbbVie’s logo look like?

Complete history of Thomas Hurwich stock trades at AbbVie

AbbVie executives and stock owners

AbbVie executives and other stock owners filed with the SEC include:

• Richard Gonzalez, Chairman of the Board, Chief Executive Officer
• Laura Schumacher, Vice Chairman, External Affairs and Chief Legal Officer
• Carlos Alban, Vice Chairman, Chief Commercial Officer
• William Chase, Executive Vice President – Finance and Administration
• Michael Severino, President, Vice Chairman
• Timothy Richmond, Chief Human Resource Officer, Executive Vice President
• Robert Michael, Chief Financial Officer, Senior Vice President
• Glenn Tilton, Lead Independent Director
• Robert Alpern, Independent Director
• Edward Rapp, Independent Director
• Frederick Waddell, Independent Director
• Melody Meyer, Independent Director
• William Burnside, Independent Director
• Roxanne Austin, Independent Director
• Brett Hart, Independent Director
• Edward Liddy, Independent Director
• Rebecca Roberts, Independent Director
• Brian Durkin, Vice President, Controller
• Jeffrey Stewart, Senior Vice President, U.S. Commercial Operations
• Nicholas Donoghoe, Senior Vice President – Enterprise Innovation
• Azita Saleki-Gerhardt, Executive Vice President – Operations
• Henry Gosebruch, Executive Vice President, Chief Strategy Officer
• Thomas A. Hurwich, VP, Controller
• Roy S Roberts, Director
• Laboratories Abbott, 10% owner
• John M. Leonard, SVP, Chief Scientific Officer